(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRIAL SNAPSHOT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRIAL SNAPSHOT

ST13

US500000098174077

Class

35, 42

Filing

98174077

Registration

7682192

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

02/04/2025

Trademark type

Word

Nice classes

35, 42

Filing date

09/11/2023

Registration date

02/04/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/30/2024

First use in commerce

09/30/2024

Drawing code

4

Owner type

16

Owner location

Lexington, MA

Examiner

WELCH, KATHERINE

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TriCan Health, LLC

Representatives

TriCan Health, LLC

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trialsproviding information management services; Providing independent review of clinical trials for business purposes; Recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Class 42

Providing information in the field of clinical research via a website; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/10/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/10/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/21/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/21/2024

EX1G

SOU EXTENSION 1 GRANTED

12/21/2024

EXT1

SOU EXTENSION 1 FILED

12/17/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/17/2024

IUAF

USE AMENDMENT FILED

10/07/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/07/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/18/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/23/2024

PUBO

PUBLISHED FOR OPPOSITION

04/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/19/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/14/2024

GNRT

NON-FINAL ACTION E-MAILED

02/14/2024

CNRT

NON-FINAL ACTION WRITTEN

02/14/2024

DOCK

ASSIGNED TO EXAMINER

02/05/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/22/2023

NWAP

NEW APPLICATION ENTERED

09/11/2023

Continuous trademark protection

Get notified about every new filing that threatens TRIAL SNAPSHOT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.